QuickView for RNA polymerase III type 2 promoter sequence-specific DNA binding (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
2. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
3. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
4. Liver Pharmacology and Xenobiotic Response Repertoire
5. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations

There were no matches for RNA polymerase III type 2 promoter sequence-specific DNA binding

1. Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy…